Ash A. Alizadeh
Researcher Next ID · RN-026961
Researcher · Biochemistry, Genetics and Molecular Biology
California Institute for Regenerative Medicine
San Francisco, India
- Works count
- 603
- Citation count
- 78,455
- H-index
- 92
- i10-index
- 194
Research interests
Publications
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment
Cell · 2023 · 10.1016/j.cell.2023.01.035
Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx
Methods in molecular biology · 2020 · 10.1007/978-1-0716-0301-7_7
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.0147
Integrating genomic features for non-invasive early lung cancer detection
Nature · 2020 · 10.1038/s41586-020-2140-0
Determining cell type abundance and expression from bulk tissues with digital cytometry
Nature Biotechnology · 2019 · https://doi.org/10.1038/s41587-019-0114-2
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
Methods in molecular biology · 2018 · https://doi.org/10.1007/978-1-4939-7493-1_12
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-17-0716
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Nature Communications · 2016 · 10.1038/ncomms11815
Integrated digital error suppression for improved detection of circulating tumor DNA
Nature Biotechnology · 2016 · 10.1038/nbt.3520
The prognostic landscape of genes and infiltrating immune cells across human cancers
Nature Medicine · 2015 · https://doi.org/10.1038/nm.3909
Robust enumeration of cell subsets from tissue expression profiles
Nature Methods · 2015 · 10.1038/nmeth.3337
Toward understanding and exploiting tumor heterogeneity
Nature Medicine · 2015 · 10.1038/nm.3915
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine · 2014 · 10.1038/nm.3519
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Proceedings of the National Academy of Sciences · 2012 · 10.1073/pnas.1121623109
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Cell · 2010 · 10.1016/j.cell.2010.07.044
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Science Translational Medicine · 2010 · 10.1126/scitranslmed.3001375
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Cell · 2009 · 10.1016/j.cell.2009.05.045
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds
PLoS Biology · 2004 · 10.1371/journal.pbio.0020007
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
New England Journal of Medicine · 2004 · 10.1056/nejmoa032520
Individuality and variation in gene expression patterns in human blood
Proceedings of the National Academy of Sciences · 2003 · 10.1073/pnas.252784499
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
The Journal of Experimental Medicine · 2001 · 10.1084/jem.194.11.1639
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns
Genome biology · 2000 · 10.1186/gb-2000-1-2-research0003
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Nature · 2000 · 10.1038/35000501
Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays
Nature Genetics · 1999 · 10.1038/14385
Genome-wide analysis of DNA copy-number changes using cDNA microarrays
Nature Genetics · 1999 · 10.1038/12640
Current projects
No projects listed.